Canadian Society of Clinical Chemists
Canadian Society of Clinical Chemists position paper: standardization of selected polypeptide hormone measurements
Contenu en anglais
Synthèse
This Canadian Society of Clinical Chemists (CSCC) sponsored position statement addresses the problem of nonuniformity of standardization of polypeptide hormone analyses. First we review the structural diversity of selected polypeptide hormones including growth hormone (GH), prolactin, follitropin (FSH), lutropin (LH), human chorionic gonadotropin (hCG), and thyrotropin (TSH) and the problem that this heterogeneity creates. The history and availability of reference materials for the analyses of these hormones are then summarized. Finally we make a list of recommendations regarding standardization, methods of measurement, and reporting of polypeptide hormone results. Implementation of the recommendations will lead to improvement in inter-laboratory comparability and more useful hormone assays.
Prognia résume cette recommandation à des fins de consultation et d’enseignement. Il ne s’agit pas d’un avis médical. Vérifiez toujours la recommandation officielle et les protocoles locaux en vigueur avant de l’appliquer.
Supports pédagogiques
En bref
- Organisme
- Canadian Society of Clinical Chemists
Autres recommandations en sciences fondamentales
- Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studiesunknown · 1992
- Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction ConsortiumUK Huntington's Prediction Consortium · 1992
